THE IMPACT OF NARRATIVE REPORTS ABOUT VACCINE ADVERSE EVENTS ON VACCINATION RISK PERCEPTION: A SIMULATION OF AN ONLINE PATIENT NETWORK Frank Renkewitz,

Slides:



Advertisements
Similar presentations
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Advertisements

ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Preparing for the First Hourly Summer Term. Summer Term Course Structure Probability and Design Issues  Descriptive Statistics, Confidence Intervals.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
ClinicalTrials.gov Stephen Kiyoi
Common Problems in Writing Statistical Plan of Clinical Trial Protocol Liying XU CCTER CUHK.
Non-Experimental designs: Developmental designs & Small-N designs
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
BS704 Class 7 Hypothesis Testing Procedures
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
Efsa LEARNING PROGRAMME Module 4 - Session 4.5a Non - Probability Sampling Methods.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Association vs. Causation
BC Jung A Brief Introduction to Epidemiology - XI (Epidemiologic Research Designs: Experimental/Interventional Studies) Betty C. Jung, RN, MPH, CHES.
Problem A newly married couple plans to have four children and would like to have three girls and a boy. What are the chances (probability) their desire.
 Be familiar with the types of research study designs  Be aware of the advantages, disadvantages, and uses of the various research design types  Recognize.
Evidence-Based Medicine 4 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
What is a Clinical Trial (alpha version) John M. Harris Jr., MD President Medical Directions, Inc.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Evidence-Based Medicine 3 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.
European Society of Cardiology Cardiovascular diseases in women.
Postmarketing Safety Assessment of Osteonecrosis of the Jaw Pamidronate & Zoledronic Acid Division of Drug Risk Evaluation Office of Drug Safety FDA Carol.
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
From Theory to Practice: Inference about a Population Mean, Two Sample T Tests, Inference about a Population Proportion Chapters etc.
Grobman, K. H. "Confirmation Bias." Teaching about. Developmentalpsychology.org, Web. 16 Sept Sequence Fits the instructor's Rule? Guess.
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
BINOMIALDISTRIBUTION AND ITS APPLICATION. Binomial Distribution  The binomial probability density function –f(x) = n C x p x q n-x for x=0,1,2,3…,n for.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Gathering Useful Data. 2 Principle Idea: The knowledge of how the data were generated is one of the key ingredients for translating data intelligently.
EXPERIMENTAL EPIDEMIOLOGY
Purpose The purpose of this study was to examine the influence of the terms AND and DNR on decisional conflict in surrogate decision-makers. Decisional.
Research Methods in Psychology Chapter 2. The Research ProcessPsychological MeasurementEthical Issues in Human and Animal ResearchBecoming a Critical.
Parent Beliefs Regarding Acceptability of Recruitment Methods in Pediatric Research Susan T. Heinze, M.S., Amy J. Majewski, B.A., Elaine C. Bennaton, B.A.,
Guidelines for Critically Reading the Medical Literature John L. Clayton, MPH.
 Variables – Create an operational definition of the things you will measure in your research (How will you observe and measure your variables?) 
Signal identification and development I.Ralph Edwards.
Handbook for Health Care Research, Second Edition Chapter 7 © 2010 Jones and Bartlett Publishers, LLC CHAPTER 7 Designing the Experiment.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Systematic Review and Meta-Analysis.
METHODS IN BEHAVIORAL RESEARCH NINTH EDITION PAUL C. COZBY.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
Proprietary & Confidential 1 Drug Efficacy in the Wild Tim Vaughan 8-Sep-2011.
Methodological Issues in Implantable Medical Device(IMDs) Studies Abdallah ABOUIHIA Senior Statistician, Medtronic.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
THE MEDICAL EXPERTISE BIAS. HOW TO BECOME THE EPISTEMIC AUTHORITY FOR YOUR PATIENTS? Katarzyna Stasiuk 1, Yoram Bar Tal 2, Renata Maksymiuk 1 1 Maria Curie.
Table 1. Methodological Evaluation of Observational Research (MORE) – observational studies of incidence or prevalence of chronic diseases Tatyana Shamliyan.
Lesson 9 Basis and taxonomy for studying relationships between two variables 1.
Efficacy and Safety of Medicines
Fibromyalgia Impact Questionnaire McGill Pain Questionnaire
Patient Focused Drug Development An FDA Perspective
Patient Involvement in the HTA Decision Making Process
1st International Online BioMedical Conference (IOBMC 2015)
8. Causality assessment:
Alcohol, Other Drugs, and Health: Current Evidence
How Patients Discuss Their Risk: Words and Numbers
Pharmacovigilance in clinical trials
Strategies to incorporate pharmacoeconomics into pharmacotherapy
Critical Reading of Clinical Study Results
Aiying Chen, Scott Patterson, Fabrice Bailleux and Ehab Bassily
Progress Report on the Patient Reported Outcomes Harmonization Team
Common Problems in Writing Statistical Plan of Clinical Trial Protocol
Writing Cochrane Protocol Cochrane Thailand Workshop 2017
Tim Auton, Astellas September 2014
This presentation has been prepared by Vault Intelligence Limited (“Vault") and is intended for off line demonstration, presentation and educational purposes.
Regulatory Perspective of the Use of EHRs in RCTs
Presentation transcript:

THE IMPACT OF NARRATIVE REPORTS ABOUT VACCINE ADVERSE EVENTS ON VACCINATION RISK PERCEPTION: A SIMULATION OF AN ONLINE PATIENT NETWORK Frank Renkewitz, Cornelia Betsch, Niels Haase University of Erfurt

Renkewitz, Betsch, & Haase, Health Information and the Internet Increasing number of people uses the Internet to obtain health information (Fox & Jones, 2008, Kummervold et al., 2008) Recent trend: Web 2.0 applications / social media ▫ Social patient networks (patientslikeme.com, “PLM”) ▫ Promote interaction and provide user generated content ▫ Provide opportunity to…  Share experiences with treatments and medications  Find other patients matched on clinical or demographic characteristics  Learn from aggregated data reports of other users An example… SMDM 2012, Oslo

Renkewitz, Betsch, & Haase, Simulated Social Network – PLM SMDM 2012, Oslo Pie-Chart on side effects:

Renkewitz, Betsch, & Haase, Simulated Social Network – PLM SMDM 2012, Oslo “Individual patient evaluations” - Narrative reports:

Renkewitz, Betsch, & Haase, Social Patient Networks SMDM 2012, Oslo Positive Evaluations (Frost et al. 2008, 2011; Wicks et al., 2010) ▫ Patients assess PLM as beneficial ▫ Help in starting / stopping medication; changing dosages ▫ Social support Problems: ▫ Self-selected and non-representative sample of users  Relative frequency of reports about effective treatments and side- effects may be biased. ▫ Source of narrative descriptions of treatments and side effects → Narrative Bias. Narrative Bias (e.g., Betsch et al., 2010, 2011; Fagerlin et al., 2005) : ▫ Narratives affect judgments and decisions in the presence of more reliable statistical information  when the number of narratives is small  when the sampling procedure is unknown

Renkewitz, Betsch, & Haase, Research Question How does the information environment available in online patient networks affect risk perceptions and decisions regarding pharmaceuticals? ▫ Domain: Vaccination and vaccine adverse events (VAE) SMDM 2012, Oslo

Renkewitz, Betsch, & Haase, Study SMDM 2012, Oslo Online experiment ▫ 458 participants (85% female, Mean age: 32, highly educated) Procedure: ▫ Information on a hypothetical disease (“Dysomerie”) ▫ Highly infectious, severe symptoms (fever, emesis, meningitis) ▫ Recommendation to vaccinate ▫ Statistical information on VAEs (WHO survey) – 20% ▫ Further information from a patient network IVs ▫ Disclaimer: “bias awareness” vs. control ▫ Relative Frequency of VAEs: 5%, 35% or 85% discounted? ▫ Type of information: pie chart, narratives or both Design: 2 x 3 x 3 between-subjects; random assignment

Renkewitz, Betsch, & Haase, Study SMDM 2012, Oslo DVs ▫ Perceived risk of vaccinating (scroll bar) ▫ Intention to vaccinate (7-point scale)

Renkewitz, Betsch, & Haase, Results – Perceived Risk SMDM 2012, Oslo Effect of relative frequency of VAEs: summary statistics:r =.27 narratives:r =.44 both:r =.48

Renkewitz, Betsch, & Haase, SMDM 2012, Oslo Results – Perceived Risk Effect of relative frequency of VAEs: bias awareness:r =.34 control:r =.46 Disclaimer effect:

Renkewitz, Betsch, & Haase, Results – Intention SMDM 2012, Oslo Effect of relative frequency of VAEs: summary statistics:r = -.14 narratives:r = -.25 both:r = -.35

Renkewitz, Betsch, & Haase, SMDM 2012, Oslo Results – Intention Effect of relative frequency of VAEs: bias awareness:r = -.17 control:r = -.33 Disclaimer effect:

Renkewitz, Betsch, & Haase, Conclusion Biased sampling in online patient networks has the potential to affect risk perceptions and treatment decisions. Narrative information had a stronger impact than summary statistics. ▫ Evidence for a narrative bias ▫ This bias occurred even though the narratives were rather “frugal”. Highly selected samples were not discounted. A bias-disclaimer may reduce the effect. SMDM 2012, Oslo

Renkewitz, Betsch, & Haase, Thank you! SMDM 2012, Oslo Conflicts of interest: none Betsch, C., Renkewitz, F. & Haase, N. (in press). Medical Decision Making.

Renkewitz, Betsch, & Haase, SMDM 2012, Oslo

Renkewitz, Betsch, & Haase, Disclaimers SMDM 2012, Oslo Bias awareness: In contrast to results from clinical studies, the patient reports published here are not representative of the experiences of all people who have received the respective medical product. The authors independently registered at the Patientenportal.de and voluntarily reported their experiences without being asked to do so. Therefore, it is possible that a self-selection is present. The published reports represent only the authors’ individual perceptions. Control (taken from PLM): While there is much information learned from clinical trials, they do not fully reflect the way a medical product is used in real life. By completing these reports, you can help improve the outcomes and safety of patients by contributing real world safety data to drug manufacturers and regulators.

Renkewitz, Betsch, & Haase, Dependent variables ConstructScale typeWording RiskRisk bar How risky do you think is the vaccination? 0 = not at all risky, 100 = very risky Intention7-point scale If you had the possibility to get vaccinated during the next week, what would you do? (1 = definitely not vaccinate, 7 = definitely vaccinate) Subjective probability 7-point scale What is the probability of vaccine-adverse events if you are getting the vaccination? (1 = almost zero, 2 = very low, 3 = low, 4 = moderate, 5 = high, 6 = very high, 7 = almost sure). Severity7-point scale How severe do you think the side-effects of the vaccination are? (1 = not severe; 7 = very severe).